HealthLeaders Media January 3, 2024
Reuters

The FDA approved nearly 50% more novel drugs in 2023 than in 2022, putting it back on...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, FDA, Govt Agencies, Pharma / Biotech
Medicare and Medicaid would cover Ozempic, Wegovy under new Biden rule
Pharma Pulse 11/25/24: Deepening Patient Relationships, Menopause May Increase Risk of Asthma & more
Axolotl Biosciences Brings Biotech to the Forefront at Formnext 2024
Innovative approach maps gene activity in the living human brain
Trump tariffs could drive up generic drug costs: 5 takeaways

Share This Article